{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibuiygkshdk4mqfnoxbcvqflr7ep5sb3fa4potmpwoewcfttluxya",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjfrbi6vnfa2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiafnkvfal2zxs3mesm27jcghfs5cbdiotnn52npqnlln73q5cn2ji"
    },
    "mimeType": "image/jpeg",
    "size": 165710
  },
  "path": "/2026/04/13/vinay-prasad-replacement-fda-cber/?utm_campaign=rss",
  "publishedAt": "2026-04-13T08:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "First Opinion",
    "Lab Dish",
    "Opinions+",
    "FDA",
    "Policy",
    "STAT+"
  ],
  "textContent": "Who would want to be the head of the FDA's Center for Biologics Evaluation and Research?",
  "title": "Opinion: STAT+: Landmines await Vinay Prasad’s successor at the FDA",
  "updatedAt": "2026-04-10T19:14:53.000Z"
}